Artificial intelligence in the interpretation of breast cancer on MRI
- 25 July 2019
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 51 (5) , 1310-1324
Abstract
Advances in both imaging and computers have led to the rise in the potential use of artificial intelligence (AI) in various tasks in breast imaging, going beyond the current use in computer‐aided detection to include diagnosis, prognosis, response to therapy, and risk assessment. The automated capabilities of AI offer the potential to enhance the diagnostic expertise of clinicians, including accurate demarcation of tumor volume, extraction of characteristic cancer phenotypes, translation of tumoral phenotype features to clinical genotype implications, and risk prediction. The combination of image‐specific findings with the underlying genomic, pathologic, and clinical features is becoming of increasing value in breast cancer. The concurrent emergence of newer imaging techniques has provided radiologists with greater diagnostic tools and image datasets to analyze and interpret. Integrating an AI‐based workflow within breast imaging enables the integration of multiple data streams into powerful multidisciplinary applications that may lead the path to personalized patient‐specific medicine. In this article we describe the goals of AI in breast cancer imaging, in particular MRI, and review the literature as it relates to the current application, potential, and limitations in breast cancer.Level of Evidence: 3Technical Efficacy: Stage 3J. Magn. Reson. Imaging 2020;51:1310–1324.Keywords
This publication has 72 references indexed in Scilit:
- Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant TherapyJNCI: Journal of the National Cancer Institute, 2013
- PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancerBreast Cancer Research and Treatment, 2012
- Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIALRadiology, 2012
- Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?Breast Cancer Research and Treatment, 2012
- Mammographic density and breast cancer risk: current understanding and future prospectsBreast Cancer Research, 2011
- Association of Computerized Mammographic Parenchymal Pattern Measure with Breast Cancer Risk: A Pilot Case-Control StudyRadiology, 2011
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- Breast MRI lesion classification: Improved performance of human readers with a backpropagation neural network computer‐aided diagnosis (CAD) systemJournal of Magnetic Resonance Imaging, 2006
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Quantitative Classification of Mammographic Densities and Breast Cancer Risk: Results From the Canadian National Breast Screening StudyJNCI: Journal of the National Cancer Institute, 1995